Insider Elizabeth Reed plans TVTX share sale

Elizabeth Reed has filed a notice of intent to sell 10,000 shares of TVTX common stock.

Accepted by SEC EDGAR 02/17/2026 - 04:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Elizabeth Reed has filed a notice of intent to sell 10,000 shares of TVTX common stock. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of February 17, 2026, and an aggregate market value of $278,317.

The 10,000 shares to be sold were acquired the same day through a stock option exercise from the issuer, paid in cash. Over the prior three months, Reed also sold TVTX common shares on several dates, generating gross proceeds ranging from $96,360.09 to $273,420.00 per transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for TVTX by Elizabeth Reed show?

The filing shows Elizabeth Reed plans to sell 10,000 TVTX common shares through Morgan Stanley on NASDAQ. The shares, valued at $278,317, were acquired by cash stock option exercise on February 17, 2026, and are being sold under Rule 144.

How many TVTX shares is Elizabeth Reed planning to sell under this Form 144?

Elizabeth Reed plans to sell 10,000 shares of TVTX common stock. The notice lists an aggregate market value of $278,317 for this block, with the transaction expected to occur on or about February 17, 2026, on the NASDAQ market.

How did Elizabeth Reed acquire the 10,000 TVTX shares she plans to sell?

The 10,000 TVTX shares were acquired via stock option exercise on February 17, 2026. The filing states the shares were obtained from the issuer and paid for in cash, immediately preceding the planned sale under Rule 144.

Which broker will handle Elizabeth Reed’s planned TVTX share sale?

The planned sale of 10,000 TVTX shares will be handled by Morgan Stanley Smith Barney LLC. The broker’s Executive Financial Services office at One New York Plaza in New York is listed, with the shares expected to trade on the NASDAQ exchange.

What recent TVTX share sales by Elizabeth Reed are disclosed in the filing?

The notice reports prior TVTX common stock sales over the past three months. These include transactions on January 20, 2026, and February 3 and 4, 2026, with individual trades generating gross proceeds such as $273,420.00 and $230,463.88.

What representation does Elizabeth Reed make about TVTX in the Form 144 notice?

By signing the notice, the seller represents she does not know any undisclosed material adverse information about TVTX’s current or prospective operations. This representation is required under Rule 144 when filing an intent to sell restricted or control securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001283303
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TRAVERE THERAPEUTICS, INC.
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Drive Suite 300 San Diego CALIFORNIA 92130
Phone	888-969-7879
Name of Person for Whose Account the Securities are To Be Sold	ELIZABETH REED
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	278317.00	89472327	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Stock Option Exercise	ISSUER			10000	02/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ELIZABETH REED 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	02/04/2026	2994	96360.09
ELIZABETH REED 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	02/03/2026	7175	230463.88
ELIZABETH REED 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	01/20/2026	10000	273420.00

144: Remarks and Signature

Remarks
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Elizabeth E. Reed
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)